Prospect Radar · 2026-08-26
AM edition
Research candidates, NOT trade signals. Configuration: quiet name + first substantive touch by a graded author + no mechanics poison. Base rate: such touches precede a ±10% move ~1.5× more often than chance — direction unknown. These are names worth YOUR research today.
HROW — via @JonahLupton↗ (grade A)
- crowd: 2 authors / 2 signals · 5d run +4.6% · no listed options
- thesis: Discloses a fund long backed by a multi-year revenue, margin, EBITDA, and valuation thesis.
- receipt: tweet ↗
WOR.AX — via @BlackScholesMan↗ (grade A, hot hand)
- crowd: 1 authors / 2 signals · 5d run +0.0% · no listed options
- thesis: Reports a large new WOR.AX purchase backed by a five-year historical return claim.
- receipt: tweet ↗
MO — via @FroehlichThors1↗ (grade A)
- crowd: 2 authors / 2 signals · 5d run +4.4% · no listed options
- thesis: Explicitly recommends accumulating Altria for pricing power and a potential 20–30% eventual yield.
- receipt: tweet ↗
TSCO — via @MattJMcClintock↗ (grade A, hot hand)
- crowd: 2 authors / 3 signals · 5d run +1.9% · no listed options
- thesis: Detailed bearish research argues TSCO's initiatives failed and its withdrawn long-term framework was unrealistic.
- receipt: tweet ↗
CXW — via @davevermilion↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
- thesis: Explicitly says he continues buying prison operators while mocking AI and robotaxi TAM claims.
- receipt: tweet ↗
GEO — via @davevermilion↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run +4.0% · no listed options
- thesis: Explicitly says he continues buying prison operators while mocking AI and robotaxi TAM claims.
- receipt: tweet ↗
LABU — via @labubu_trader↗ (grade A)
- crowd: 4 authors / 4 signals · 5d run +0.0% · no listed options
- thesis: Discloses existing TLT calls and leveraged-equity holdings based on an expected long-bond short squeeze.
- receipt: tweet ↗
ALNY — via @harry03994688↗ (grade A)
- crowd: 1 authors / 4 signals · 5d run +5.0% · no listed options
- thesis: Author compares biotech platforms and argues ABCL could join REGN and ALNY above a 50% approval-success potential.
- receipt: tweet ↗
NAIL — via @labubu_trader↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
- thesis: Discloses existing TLT calls and leveraged-equity holdings based on an expected long-bond short squeeze.
- receipt: tweet ↗
JPY — via @MacroAlphaHQ↗ (grade A, hot hand)
- crowd: 1 authors / 1 signals · 5d run +0.7% · no listed options
- thesis: Author argues Japan's policy constraint protects bonds at the yen's expense.
- receipt: tweet ↗
APO — via @TylerHardt↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run -0.5% · no listed options
- thesis: Warns private-credit firms face a software-debt maturity cliff beginning in 2028.
- receipt: tweet ↗
BX — via @TylerHardt↗ (grade A)
- crowd: 3 authors / 4 signals · 5d run +2.0% · no listed options
- thesis: Warns private-credit firms face a software-debt maturity cliff beginning in 2028.
- receipt: tweet ↗
PM edition
Research candidates, NOT trade signals. Configuration: quiet name + first substantive touch by a graded author + no mechanics poison. Base rate: such touches precede a ±10% move ~1.5× more often than chance — direction unknown. These are names worth YOUR research today.
MO — via @FroehlichThors1↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run +4.7% · no listed options
- thesis: Explicitly recommends accumulating Altria for pricing power and a potential 20–30% eventual yield.
- receipt: tweet ↗
APH — via @SayNoToTrading↗ (grade A)
- crowd: 2 authors / 2 signals · 5d run +3.4% · no listed options
- thesis: Explicitly states an imminent plan to double the APH share count.
- receipt: tweet ↗
GEO — via @davevermilion↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run +6.8% · no listed options
- thesis: Explicitly says he continues buying prison operators while mocking AI and robotaxi TAM claims.
- receipt: tweet ↗
CTOS — via @InvestiBrew↗ (grade A, hot hand)
- crowd: 1 authors / 3 signals · 5d run +0.0% · no listed options
- thesis: Argues CTOS merits its valuation due to margins, cash flow, utilization and AI exposure.
- receipt: tweet ↗
CXW — via @davevermilion↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
- thesis: Explicitly says he continues buying prison operators while mocking AI and robotaxi TAM claims.
- receipt: tweet ↗
ZTS — via @KrisPatel99↗ (grade A)
- crowd: 3 authors / 4 signals · 5d run +1.1% · no listed options
- thesis: Says the technical setup is attractive enough to buy amid a healthcare rotation thesis.
- receipt: tweet ↗
BWXT — via @pennycheck↗ (grade A)
- crowd: 3 authors / 5 signals · 5d run -5.6% · no listed options
- thesis: Author says they bought BWXT after its selection to deploy an advanced reactor for the Army's Janus program.
- receipt: tweet ↗
ATS.VI — via @KairosPraxis↗ (grade A, hot hand)
- crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
- thesis: Discloses concentrated long exposure to AI-optics names with a durable bullish thesis.
- receipt: tweet ↗
DNUT — via @jonathanmaze↗ (grade A)
- crowd: 1 authors / 2 signals · 5d run -1.7% · no listed options
- thesis: Explains structural flaws in Krispy Kreme's store and logistics economics and doubts the turnaround.
- receipt: tweet ↗
INTR — via @Biotech2k1↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run +3.9% · no listed options
- thesis: Explicit South America plan combines core holds with future entries conditional on a pullback.
- receipt: tweet ↗